Quantitative analysis for Senseonics Holdings, Inc. (SENS) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Strong Buy (92.0) (grade A). 26 signals analyzed (21 differentiated alt-data).
SENS stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $7.45 | $7.14 | $7.18 |
| 2026-05-08 | $5.83 | $4.80 | $5.03 |
| 2026-05-20 | $5.74 | $5.48 | $5.71 |
| 2026-06-02 | $7.23 | $6.67 | $6.87 |
| 2026-06-12 | $7.68 | $7.13 | $7.18 |
| 2026-06-25 | $5.77 | $5.33 | $5.39 |
| 2026-07-08 | $5.45 | $5.12 | $5.31 |
| 2026-07-20 | $5.18 | $5.05 | $5.10 |
| 2026-07-30 | $5.17 | $4.89 | $5.07 |
| 2026-08-12 | $8.52 | $7.60 | $7.93 |
| 2026-08-24 | $9.98 | $9.21 | $9.38 |
| 2026-09-03 | $10.08 | $9.46 | $9.90 |
How Senseonics Holdings, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| PMI | Picard Medical, Inc. | $240M | — |
| ACHV | Achieve Life Sciences, Inc. | $244M | 42.0 |
| PRLD | Prelude Therapeutics Incorporated | $251M | — |
| CGEN | Compugen Ltd. | $256M | — |
View all Health Care stocks by valuation and signals →
Senseonics Holdings, Inc. (SENS) scores Strong Buy (92.0), and the composite conceals a 66-point disagreement between its dimensions. It is strongest on competitive moat at 92 and valuation at 72, and weakest on technicals at 26. A stock can carry competitive moat that high while technicals sits at 26; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| competitive moat | 92 |
| valuation | 72 |
| earnings quality | 51 |
| analyst consensus | 50 |
| technicals | 26 |
StoQuant analyzes 26 signals (21 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Senseonics Holdings, Inc. (SENS): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/SENS"><img src="https://stoquant.com/badge/SENS.svg" alt="Senseonics Holdings, Inc. (SENS) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.